Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2002
05/29/2002CN1350846A Isopentyl nitrite
05/29/2002CN1350845A Medicine for treating chronic granulocytic leukemia
05/29/2002CN1350844A Lentrial plaster for first aid
05/29/2002CN1350843A Isosorbide dinitrate plaster for first aid
05/29/2002CN1350842A Lipoid and its application in medicines
05/29/2002CN1085674C Safflower total uranidin, its preparation and application
05/29/2002CN1085672C Phospholipid derivatives of phosphono-carboxylic acids, prodn, and use as antiviral
05/29/2002CN1085668C 6-[triazoly[3-(trifluoromethyl)phenyl)methyl]-2-quinolinones and quinolinethiones
05/29/2002CN1085667C Substituted tetracylic azepine derivatives having affinity for 5-HT2 receptors
05/29/2002CN1085666C 6-aryl pyrido (2,3-d) pyrimidines and naphthyridines for inhibiting protein tyro sine kinase medicated cellular proliferation
05/29/2002CN1085663C Aromatic amino ethers as pain relieving agents
05/29/2002CN1085659C 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
05/29/2002CN1085550C Medicine for rheumatism and its preparation
05/29/2002CN1085541C Chinese medicine for treating calculus hydrops of liver, gall and kidney (CN)
05/29/2002CN1085538C Chinese medicine for curing gastric cancer and esophagus cancer
05/29/2002CN1085537C Hog cholera treating medicine
05/29/2002CN1085534C Hemorrhoids paste
05/29/2002CN1085531C Preparation for protecting liver and relieving acute alcoholism and its preparing method
05/29/2002CN1085530C External use medicine for treating open wound
05/29/2002CN1085529C Use of [R-(Z)]-alpha-(methoxyimino)-alpha-[1-azabicyclw[2.2.2.]oct-3-yl] acetonitrile to reduce amyloid beta A4 formation in Alzheimers disease
05/29/2002CN1085528C Use of benzydamine in treatment of pathological conditions caused by TNF
05/29/2002CN1085527C Preparation method of synergistic antimalarial compound benzfluorenol
05/29/2002CN1085526C Air pressed package using polyoxyethylene glyceryl oleate
05/29/2002CN1085525C Air pressed package using polyoxyethyene glyceryl oleate
05/29/2002CN1085523C Preparation of epidermis and process for its preparation
05/29/2002CA2363823A1 Production of solid preparations of water-soluble, sparingly water-solubile or water-insoluble active compounds
05/28/2002USRE37721 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
05/28/2002US6395961 Gene transfer in chickens by introduction of DNA into muscle in ovo
05/28/2002US6395960 A genetically engineered rodent; diagnosis and therapy for alzheimer's disease
05/28/2002US6395923 Antiischemic agents; cardiovascular disorders
05/28/2002US6395919 Calcilytic compounds
05/28/2002US6395909 Drugs for anticonvulsants
05/28/2002US6395905 Tetrahydroindazole derivatives as ligands for GABA-A α 5 receptors
05/28/2002US6395901 Multistage reaction with calcium borohydride, alkylsulfonyl chloride, alkali metal mercapto compound and reducing agent for preparation of compounds active in the treatment of parkinson's disease,
05/28/2002US6395893 Crystallization of lactitol, crystalline lactitol product and use thereof
05/28/2002US6395886 Anticancer agents
05/28/2002US6395876 High-affinity tryptophan transporter
05/28/2002US6395788 Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine
05/28/2002US6395787 Prostaglandin f2a 1-ethanolamide derivatives; vision defects
05/28/2002US6395786 Sleep inducing agent
05/28/2002US6395785 E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof
05/28/2002US6395784 Obesity, hypercholesterolemia, atherosclerosis, thyroid cancer, hypothyroidism, osteoporosis, depression, arrhythmia, and congestive heart failure treatment
05/28/2002US6395783 Treatment of PCP addiction and PCP addiction-related behavior
05/28/2002US6395782 Method of increasing longevity and preventing body weight wasting in autoimmune disease by using conjugated linoleic acid
05/28/2002US6395781 Reducing vascular diameter
05/28/2002US6395780 Prevent glucose degradation
05/28/2002US6395779 Method of treatment using peroxidized lipids
05/28/2002US6395777 Ionic polymers as anti-infective agents
05/28/2002US6395773 Anti-drug resistant strain agents and antichlamydia agents
05/28/2002US6395772 Method for blocking endothelial cell-leukocyte attachment by inhibiting expression of adhesion molecules on the vascular endothelium for therapeutic applications
05/28/2002US6395770 Method and compositions for administering taxanes orally to human patients
05/28/2002US6395769 2-arylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome
05/28/2002US6395768 Preventing cytotoxic effect of amyloid protein; oxidation, stress resistance
05/28/2002US6395767 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
05/28/2002US6395766 Cognition activators
05/28/2002US6395765 Parasiticides
05/28/2002US6395764 Nosal decongestion, respiratory system disorders
05/28/2002US6395763 Antitumor, anticancer agents; immunosuppressant
05/28/2002US6395759 Psychological disorders
05/28/2002US6395758 Small molecule carbamates or ureas for vision and memory disorders
05/28/2002US6395757 Method for treating hot flashes in humans
05/28/2002US6395756 Use of ophthalmic agent
05/28/2002US6395755 Urogenital system disorders; postmenopause syndroms
05/28/2002US6395754 Antiinflammatory agents, cardiovascular disorders, antipyretics
05/28/2002US6395753 Antihistamines, antiallergens, antiarthritic agents
05/28/2002US6395752 Method of treating depression using 1-threo-methylphenidate
05/28/2002US6395751 Synergistic mixture; anticholesterol agents
05/28/2002US6395750 Drugs for the treatment of malignant tumors
05/28/2002US6395749 Carboxamide compounds, methods, and compositions for inhibiting PARP activity
05/28/2002US6395748 Use treating Alzheimer's disease; monoamine reuptake inhibitor tropanes such as tesofensine (2-methoxymethyl-3-(3,4-dichlorophenyl)-tropane)
05/28/2002US6395747 Ibudilast
05/28/2002US6395746 Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
05/28/2002US6395745 Stable, crystal structure; plant extract
05/28/2002US6395744 Administering apomorphine and androgen
05/28/2002US6395743 Aids therapy
05/28/2002US6395742 2,4-diaminopyrimidine derivatives
05/28/2002US6395740 Calcitonin mimetics
05/28/2002US6395737 Malonic acid derivatives, processes for their preparation, for their use and pharmaceutical compositions containing them
05/28/2002US6395736 Compositions and methods for the treatment of anorectal disorders
05/28/2002US6395735 An indane-like compounds which can be useful for treating psychosis and other conditions associated with modulation of a muscarinic receptor
05/28/2002US6395734 Anticancer agents
05/28/2002US6395732 Bactericides
05/28/2002US6395731 Anticoagulants
05/28/2002US6395730 Potassium channel inhibitors
05/28/2002US6395729 Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors
05/28/2002US6395728 Method of treatment and pharmaceutical composition
05/28/2002US6395727 Method of treating Bulimia Nervosa and related eating disorders by administration of atypical antipsychotic medications
05/28/2002US6395725 Prevention or reverse drug resistance
05/28/2002US6395724 Multibinding inhibitors of cyclooxygenase-2
05/28/2002US6395723 Method of providing coginition enhancement with 5α-pregnan-3β-ol-20-one sulfate
05/28/2002US6395722 Fatty acid derivatives of bile acids and bile acid derivatives
05/28/2002US6395721 Low potency unpreserved sterile topical corticosteroid compositions for dermatitis
05/28/2002US6395720 Anticancer agents
05/28/2002US6395719 Methods for increasing levels of acetylcholine
05/28/2002US6395717 Sialic acid polymer
05/28/2002US6395716 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B
05/28/2002US6395715 Antitumor agents
05/28/2002US6395712 Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy
05/28/2002US6395711 Macrolides with antitumor activity
05/28/2002US6395710 Macrolide antiinfective agents